A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL

Clinical trial NCT02518113 · COMPLETED

Trial details

NCT number: NCT02518113
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

T-cell Acute Lymphoblastic Leukemia T-cell Lymphoblastic Lymphoma

Start date: 2015-10-01
Primary completion: 2018-01-15
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.